|
PDXP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.160000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.983600E-04 |
| Normal-vs-Stage2 |
3.705400E-01 |
| Normal-vs-Stage3 |
8.978100E-02 |
| Normal-vs-Stage4 |
7.867600E-02 |
| Stage1-vs-Stage2 |
1.642650E-01 |
| Stage1-vs-Stage3 |
2.119600E-01 |
| Stage1-vs-Stage4 |
4.347800E-01 |
| Stage2-vs-Stage3 |
6.773600E-01 |
| Stage2-vs-Stage4 |
5.478000E-01 |
| Stage3-vs-Stage4 |
7.914800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.039400E-03 |
| Normal-vs-AfricanAmerican |
2.371500E-02 |
| Normal-vs-Asian |
7.072000E-01 |
| Caucasian-vs-AfricanAmerican |
3.773000E-01 |
| Caucasian-vs-Asian |
3.205800E-01 |
| AfricanAmerican-vs-Asian |
1.787420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.170100E-02 |
| Normal-vs-Female |
2.46170000000046E-05 |
| Male-vs-Female |
7.810700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.189210E-01 |
| Normal-vs-Age(41-60Yrs) |
7.477000E-03 |
| Normal-vs-Age(61-80Yrs) |
7.115000E-03 |
| Normal-vs-Age(81-100Yrs) |
4.240500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.3457000000009E-05 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.10450000000573E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.777300E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.916200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.246000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.946200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.921400E-01 |
| Normal-vs-Grade 2 |
3.823700E-03 |
| Normal-vs-Grade 3 |
7.437500E-03 |
| Normal-vs-Grade 4 |
1.836640E-01 |
| Grade 1-vs-Grade 2 |
7.317000E-01 |
| Grade 1-vs-Grade 3 |
6.910200E-01 |
| Grade 1-vs-Grade 4 |
4.787600E-01 |
| Grade 2-vs-Grade 3 |
8.652800E-01 |
| Grade 2-vs-Grade 4 |
3.696400E-01 |
| Grade 3-vs-Grade 4 |
4.465600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.89540000039968E-07 |
| Normal-vs-ccB subtype |
6.739200E-01 |
| ccA subtype-vs-ccB subtype |
4.71130001677977E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.567770E-02 |
| Normal-vs-N1 |
3.242400E-01 |
| N0-vs-N1 |
9.684800E-01 |
|
|
